H1N1 Vaccines Market: Driven By: Rise in the Prevalence of Chronic Diseases, Technological Advancements and Others
North America and Europe dominate the global H1N1 vaccines market. This is due to improved research infrastructure in these regions. The U.S. represents the largest market for H1N1 vaccines, followed by Canada, in North America. In Europe, France and Germany hold major shares of this market.
View full press release